SEARCH

SEARCH BY CITATION

References

  • Feyler, S., O’Connor, S.J.M., Rawstron, A.C., Chezhian, S., Ross, F.M., Pratt, G., Drayson, M.T., Ashcroft, J., Cook, G. & Owen, R.G. (2008) IgM myeloma: a rare entity characterized by a CD20CD56CD117 immunophenotype and the t(11;14). BJH, 140, 547551. doi:DOI: 10.1111/j.1365-2141.2007.06969.x.
  • Richardson, P.G., Sonneveld, P., Schuster, M.W., Irwin, D., Stadtmauer, E.A., Facon, T., Harousseau, J.L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., San-Miguel, J.F., Bladé, J., Boccadoro, M., Cavenagh, J., Dalton, W.S., Boral, A.L., Esseltine, D.L., Porter, J.B., Schenkein, D., Anderson, K.C. & Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators. (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. NEJM, 352, 24872498.